Effects of biological therapies on patients with Type-2 high asthma and comorbid obesity

Effects of biological therapies on patients with Type-2 high asthma and comorbid obesity

Over 20 million adults and 6 million children in the United States (US) have asthma, a chronic respiratory disease characterized by airway inflammation, bronchoconstriction, and mucus hypersecretion. Obesity, another highly prevalent disease in the US, is a major risk factor for asthma and a signifi...

Full description

Bibliographic Details
Main Authors: Diya Garg, Loretta G. Que, Jennifer L. Ingram
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Pharmacology
Subjects:
asthma
obesity
Type 2 inflammation
biomarkers
biological therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1315540/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1315540/full

Similar Items